News & Perspective

Nov 06, 2017

Nov 06, 2017

News Scan for Nov 06, 2017

Strep burden, resistance threat
Salmonella probe ends
Ebola susceptibility
MDR-TB in Minnesota

Oct 11, 2017

Oct 11, 2017
Ebola vaccine study

Liberia trial finds Ebola vaccines yield year-long immune response

A trial at the end of Liberia's Ebola outbreak shows 2 candidate vaccines posed no major safety concerns and triggered immune responses that lasted at least a year.

Oct 05, 2017

Oct 05, 2017

Flu Scan for Oct 05, 2017

Research and pandemic readiness
Reusable respirators
Monoclonal antibody partnership

Oct 03, 2017

Oct 03, 2017

News Scan for Oct 03, 2017

Saudi MERS case
Measles in the US
Pup-borne Campylobacter
H5N8 outbreaks
VHF vaccine contract
Kidney injury and antibiotics

Feb 28, 2017

Feb 28, 2017

News Scan for Feb 28, 2017

Zika study rejected
Asymptomatic Ebola
MERS cases
CEPI names CEO
Biosecurity lab in China

Oct 12, 2016

Oct 12, 2016
ZMapp Ebola drug research

Trial offers mixed view of Ebola drug ZMapp

"I would view the results . . . in an optimistic light," said lead author Richard Davey after the drug showed more than 90% efficacy.

Aug 16, 2016

Aug 16, 2016

News Scan for Aug 16, 2016

Malaria may boost Ebola survival
Scallop hepatitis A source
Inhaled vs injectable flu vaccine
Camels and human cold virus
Venezuela malaria spike

Jul 05, 2016

Jul 05, 2016

News Scan for Jul 05, 2016

Ebola survivor drug study
MERS linked to camels
Reduced antibiotics
HPV and cervical abnormalities

Apr 20, 2016

Apr 20, 2016
Ebola virus

Trial suggests potential for sequential use of 2 Ebola vaccines

Meanwhile, a different study met with disappointing results for an experimental Ebola drug in the Sierra Leone trial.

Feb 25, 2016

Feb 25, 2016
Ebola survivor in Liberia

Studies on Ebola survivors show range of complications

Findings include neurologic problems and a potential for virus survival in semen for 18 months.

Pages

Sort Results

 

Narrow results

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»